Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoBut Moderna expects the lion's share of its sales to come in the second half of 2024. That lines up...
Summer COVID bump intensifies in L.A. and California, fueled by FLiRT variants
Los Angeles Times· 11 hours agoIt remains unclear how bad the COVID situation may get this summer, however. The U.S. Centers for...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 3 days agoCOVID-19 vaccines. The Centers for Disease Control and Prevention recommends everyone 6 months and...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 5 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant...
Centers for Disease Control and Prevention· 7 days agoVaccine Effectiveness among Household Contacts
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
Los Angeles Times· 5 days agoNot only have its results become more sharply partisan, favoring Republican and conservative...
Gateway - Quartz
Quartz· 6 days agoThis week, the nation announced it would destroy 9 million doses of Moderna vaccines that have already expired, and more than 5 million more will likely ...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 6 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
Gateway - Jalopnik
Jalopnik· 7 days agoIn an article posted on CNBC on Monday, the White House had shared more than 90 percent of federal workers had received at least one COVID-19 vaccine < ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoBiotech stocks hit a two-year high in February, but have trended sideways in the months since...
